Donghua Pharmaceutical: Subsidiary receives CNAS laboratory accreditation certificate.

East Asia Pharmaceutical Industry Announcement: Wholly-owned subsidiary Hangzhou Shangli Biomedical Technology Co., Ltd. recently obtained the Laboratory Accreditation Certificate from the China National Accreditation Service for Conformity Assessment. The effective date of the certificate is May 20, 2025, and the expiration date is May 19, 2031. This accreditation marks the recognition of the management level and technical capabilities of Hangzhou Shangli's analytical laboratory by both national and international authorities, demonstrating the ability to carry out testing in accordance with national standards. This will help improve the company's product quality, research and development capabilities, and customer trust, thereby enhancing overall competitiveness and promoting high-quality development. This accreditation will not have a major impact on the company's current performance.